-
Allergan plc is an American, Irish-domiciled
pharmaceutical company that acquires, develops,
manufactures and
markets brand name
drugs and
medical devices...
-
Pharmaceuticals and
Actavis plc,
prior to the
acquisition of Irish-based
Allergan, Inc.) is a
global pharmaceutical company focused on acquiring, developing...
-
Allergan, Inc. was an
American global pharmaceutical company focused on eye care, neurosciences,
medical dermatology,
medical aesthetics,
breast enhancement...
- + Lomb by
Valeant Pharmaceuticals, and the $63
billion acquisition of
Allergan by Abbvie. He
founded the special-purpose
acquisition company (SPAC) Vesper...
- [2] "Analyst cuts
Allergan generics sales estimates as Teva deal
close nears". FiercePharma.com. June 16, 2016. "Teva to Buy
Allergan's Generic Drug Unit"...
- US and the
European Union in 2012. It is
marketed by
Abbvie (formerly
Allergan) in the
United states and by
Astellas in Asia;[citation needed] Ironwood...
- million. On 25 June 2019,
AbbVie announced it
would acquire Irish-based
Allergan plc for
about $63 billion;
however the
transaction would not be structured...
- merger,
whereby Allergan acquired Pfizer, with the new
company then
changing its name to "Pfizer, plc". On
April 6, 2016,
Pfizer and
Allergan terminated the...
-
forms are
marketed under the
brand names Botox Cosmetic/Vistabel from
Allergan, Dysport/Azzalure from
Galderma and Ipsen, Xeomin/Bocouture from Merz,...
- name GLYX-13) is a
novel antidepressant that was
under development by
Allergan (previously Naurex) as an
adjunctive therapy for the
treatment of treatment-resistant...
